Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.44
MCK's Cash to Debt is ranked higher than
61% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. MCK: 0.44 )
MCK' s 10-Year Cash to Debt Range
Min: 0.05   Max: 3.01
Current: 0.44

0.05
3.01
Equity to Asset 0.17
MCK's Equity to Asset is ranked lower than
51% of the 65 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. MCK: 0.17 )
MCK' s 10-Year Equity to Asset Range
Min: 0.17   Max: 0.35
Current: 0.17

0.17
0.35
Interest Coverage 7.81
MCK's Interest Coverage is ranked higher than
56% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.02 vs. MCK: 7.81 )
MCK' s 10-Year Interest Coverage Range
Min: 0.94   Max: 12.77
Current: 7.81

0.94
12.77
F-Score: 6
Z-Score: 4.44
M-Score: -2.30
WACC vs ROIC
6.45%
14.03%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 1.60
MCK's Operating margin (%) is ranked higher than
56% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.77 vs. MCK: 1.60 )
MCK' s 10-Year Operating margin (%) Range
Min: -0.27   Max: 2.54
Current: 1.6

-0.27
2.54
Net-margin (%) 0.99
MCK's Net-margin (%) is ranked higher than
59% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.25 vs. MCK: 0.99 )
MCK' s 10-Year Net-margin (%) Range
Min: -0.2   Max: 4.29
Current: 0.99

-0.2
4.29
ROE (%) 19.68
MCK's ROE (%) is ranked higher than
90% of the 61 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.91 vs. MCK: 19.68 )
MCK' s 10-Year ROE (%) Range
Min: -3.01   Max: 22.45
Current: 19.68

-3.01
22.45
ROA (%) 3.45
MCK's ROA (%) is ranked higher than
64% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.21 vs. MCK: 3.45 )
MCK' s 10-Year ROA (%) Range
Min: -0.9   Max: 7.46
Current: 3.45

-0.9
7.46
ROC (Joel Greenblatt) (%) 86.86
MCK's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.12 vs. MCK: 86.86 )
MCK' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -7.04   Max: 196.7
Current: 86.86

-7.04
196.7
Revenue Growth (3Y)(%) 11.50
MCK's Revenue Growth (3Y)(%) is ranked higher than
75% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. MCK: 11.50 )
MCK' s 10-Year Revenue Growth (3Y)(%) Range
Min: -7.8   Max: 26.5
Current: 11.5

-7.8
26.5
EBITDA Growth (3Y)(%) 14.20
MCK's EBITDA Growth (3Y)(%) is ranked higher than
78% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.10 vs. MCK: 14.20 )
MCK' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -52.7   Max: 171.6
Current: 14.2

-52.7
171.6
EPS Growth (3Y)(%) 10.80
MCK's EPS Growth (3Y)(%) is ranked higher than
65% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.30 vs. MCK: 10.80 )
MCK' s 10-Year EPS Growth (3Y)(%) Range
Min: -44.5   Max: 87.1
Current: 10.8

-44.5
87.1
» MCK's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

MCK Guru Trades in Q1 2014

John Burbank 1,302 sh (New)
Mario Gabelli 11,520 sh (New)
Joel Greenblatt 44,157 sh (+106.75%)
Pioneer Investments 402,758 sh (+97.89%)
Leon Cooperman 710,982 sh (+2.52%)
Jim Simons Sold Out
Andreas Halvorsen Sold Out
Vanguard Health Care Fund 7,343,200 sh (-1.43%)
Scott Black 63,383 sh (-6.95%)
Larry Robbins 2,408,550 sh (-21.06%)
Ray Dalio 31,030 sh (-45.21%)
Steven Cohen 12,995 sh (-86.62%)
Paul Tudor Jones 1,300 sh (-95.44%)
Jeremy Grantham 9,600 sh (-97.19%)
» More
Q2 2014

MCK Guru Trades in Q2 2014

Jim Simons 461,900 sh (New)
Lee Ainslie 1,719,923 sh (New)
Paul Tudor Jones 79,317 sh (+6001.31%)
Mario Gabelli 14,560 sh (+26.39%)
Larry Robbins 2,837,666 sh (+17.82%)
Pioneer Investments 465,693 sh (+15.63%)
Steven Cohen 301,500 sh (unchged)
Larry Robbins 250,000 sh (unchged)
John Burbank Sold Out
Jeremy Grantham 9,200 sh (-4.17%)
Leon Cooperman 669,775 sh (-5.8%)
Vanguard Health Care Fund 6,584,000 sh (-10.34%)
Scott Black 44,542 sh (-29.73%)
Joel Greenblatt 20,104 sh (-54.47%)
Ray Dalio 4,030 sh (-87.01%)
» More
Q3 2014

MCK Guru Trades in Q3 2014

Louis Moore Bacon 40,000 sh (New)
Jeremy Grantham 227,600 sh (+2373.91%)
Ray Dalio 17,713 sh (+339.53%)
Lee Ainslie 1,857,273 sh (+7.99%)
Pioneer Investments 464,393 sh (unchged)
Joel Greenblatt Sold Out
Leon Cooperman 652,175 sh (-2.63%)
Scott Black 43,133 sh (-3.16%)
Mario Gabelli 14,040 sh (-3.57%)
Vanguard Health Care Fund 6,342,800 sh (-3.66%)
Larry Robbins 1,866,966 sh (-34.21%)
Paul Tudor Jones 50,000 sh (-36.96%)
Jim Simons 161,100 sh (-65.12%)
Steven Cohen 85,100 sh (-71.77%)
» More
Q4 2014

MCK Guru Trades in Q4 2014

Ken Fisher 967 sh (New)
Ray Dalio 22,313 sh (+25.97%)
Mario Gabelli 17,490 sh (+24.57%)
Leon Cooperman 715,203 sh (+9.66%)
Vanguard Health Care Fund 6,342,800 sh (unchged)
Paul Tudor Jones Sold Out
Louis Moore Bacon Sold Out
Jeremy Grantham Sold Out
Jim Simons Sold Out
Pioneer Investments 463,990 sh (-0.09%)
Scott Black 38,844 sh (-9.94%)
Larry Robbins 1,352,460 sh (-27.56%)
Lee Ainslie 1,307,419 sh (-29.61%)
Steven Cohen 15,000 sh (-82.37%)
» More
» Details

Insider Trades

Latest Guru Trades with MCK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Lee Ainslie 2014-12-31 Reduce -29.61%1.57%$185.02 - $212.78 $ 228.712%1307419
Leon Cooperman 2014-12-31 Add 9.66%0.22%$185.02 - $212.78 $ 228.712%715203
Scott Black 2014-12-31 Reduce -9.94%0.12%$185.02 - $212.78 $ 228.712%38844
Ray Dalio 2014-12-31 Add 25.97%0.01%$185.02 - $212.78 $ 228.712%22313
Ken Fisher 2014-12-31 New Buy$185.02 - $212.78 $ 228.712%967
Mario Gabelli 2014-12-31 Add 24.57%$185.02 - $212.78 $ 228.712%17490
Lee Ainslie 2014-09-30 Add 7.99%0.39%$186.58 - $199.63 $ 228.719%1857273
Vanguard Health Care Fund 2014-09-30 Reduce -3.66%0.12%$186.58 - $199.63 $ 228.719%6342800
Joel Greenblatt 2014-09-30 Sold Out 0.05%$186.58 - $199.63 $ 228.719%0
Ray Dalio 2014-09-30 Add 339.53%0.02%$186.58 - $199.63 $ 228.719%17713
Lee Ainslie 2014-06-30 New Buy4.6%$164.68 - $191.63 $ 228.729%1719923
Vanguard Health Care Fund 2014-06-30 Reduce -10.34%0.37%$164.68 - $191.63 $ 228.729%6584000
Scott Black 2014-06-30 Reduce -29.73%0.36%$164.68 - $191.63 $ 228.729%44542
Joel Greenblatt 2014-06-30 Reduce -54.47%0.07%$164.68 - $191.63 $ 228.729%20104
Ray Dalio 2014-06-30 Reduce -87.01%0.04%$164.68 - $191.63 $ 228.729%4030
John Burbank 2014-06-30 Sold Out 0.01%$164.68 - $191.63 $ 228.729%0
Mario Gabelli 2014-06-30 Add 26.39%$164.68 - $191.63 $ 228.729%14560
Andreas Halvorsen 2014-03-31 Sold Out 0.95%$160.16 - $185.35 $ 228.731%0
Joel Greenblatt 2014-03-31 Add 106.75%0.06%$160.16 - $185.35 $ 228.731%44157
Ray Dalio 2014-03-31 Reduce -45.21%0.03%$160.16 - $185.35 $ 228.731%31030
Mario Gabelli 2014-03-31 New Buy0.01%$160.16 - $185.35 $ 228.731%11520
John Burbank 2014-03-31 New Buy0.01%$160.16 - $185.35 $ 228.731%1302
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about McKesson Corp

Weekly Insider Sells Highlight: HCA, MCK, P, ROP
According to GuruFocus Insider Data, the largest insider sells during the past week were: HCA Holdings Inc., McKesson Corp, Pandora Media Inc. and Roper Industries Inc. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 31.30
MCK's P/E(ttm) is ranked higher than
66% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.40 vs. MCK: 31.30 )
MCK' s 10-Year P/E(ttm) Range
Min: 8.15   Max: 37.76
Current: 31.3

8.15
37.76
Forward P/E 18.15
MCK's Forward P/E is ranked higher than
82% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.87 vs. MCK: 18.15 )
N/A
PE(NRI) 30.80
MCK's PE(NRI) is ranked higher than
66% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.70 vs. MCK: 30.80 )
MCK' s 10-Year PE(NRI) Range
Min: 8.17   Max: 34.66
Current: 30.8

8.17
34.66
P/B 5.84
MCK's P/B is ranked higher than
58% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.68 vs. MCK: 5.84 )
MCK' s 10-Year P/B Range
Min: 1.29   Max: 5.86
Current: 5.84

1.29
5.86
P/S 0.31
MCK's P/S is ranked higher than
86% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.78 vs. MCK: 0.31 )
MCK' s 10-Year P/S Range
Min: 0.08   Max: 0.32
Current: 0.31

0.08
0.32
PFCF 15.85
MCK's PFCF is ranked higher than
84% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.13 vs. MCK: 15.85 )
MCK' s 10-Year PFCF Range
Min: 4.69   Max: 41.74
Current: 15.85

4.69
41.74
POCF 13.74
MCK's POCF is ranked higher than
77% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.00 vs. MCK: 13.74 )
MCK' s 10-Year POCF Range
Min: 4.25   Max: 88.45
Current: 13.74

4.25
88.45
EV-to-EBIT 19.80
MCK's EV-to-EBIT is ranked higher than
67% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.02 vs. MCK: 19.80 )
MCK' s 10-Year EV-to-EBIT Range
Min: -118.3   Max: 23.1
Current: 19.8

-118.3
23.1
PEG 1.89
MCK's PEG is ranked higher than
85% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.81 vs. MCK: 1.89 )
MCK' s 10-Year PEG Range
Min: 0.16   Max: 4.79
Current: 1.89

0.16
4.79
Shiller P/E 41.02
MCK's Shiller P/E is ranked higher than
74% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 40.54 vs. MCK: 41.02 )
MCK' s 10-Year Shiller P/E Range
Min: 12.57   Max: 42.43
Current: 41.02

12.57
42.43
Current Ratio 1.13
MCK's Current Ratio is ranked lower than
52% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. MCK: 1.13 )
MCK' s 10-Year Current Ratio Range
Min: 1.08   Max: 1.71
Current: 1.13

1.08
1.71
Quick Ratio 0.66
MCK's Quick Ratio is ranked lower than
52% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.06 vs. MCK: 0.66 )
MCK' s 10-Year Quick Ratio Range
Min: 0.52   Max: 0.94
Current: 0.66

0.52
0.94
Days Inventory 30.66
MCK's Days Inventory is ranked higher than
88% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 52.56 vs. MCK: 30.66 )
MCK' s 10-Year Days Inventory Range
Min: 30.32   Max: 44.87
Current: 30.66

30.32
44.87
Days Sales Outstanding 34.81
MCK's Days Sales Outstanding is ranked higher than
85% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.12 vs. MCK: 34.81 )
MCK' s 10-Year Days Sales Outstanding Range
Min: 18.94   Max: 33.27
Current: 34.81

18.94
33.27

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.42
MCK's Dividend Yield is ranked lower than
90% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.75 vs. MCK: 0.42 )
MCK' s 10-Year Dividend Yield Range
Min: 0.35   Max: 1.42
Current: 0.42

0.35
1.42
Dividend Payout 0.13
MCK's Dividend Payout is ranked higher than
97% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.72 vs. MCK: 0.13 )
MCK' s 10-Year Dividend Payout Range
Min: 0.04   Max: 6
Current: 0.13

0.04
6
Dividend growth (3y) 8.50
MCK's Dividend growth (3y) is ranked higher than
62% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.90 vs. MCK: 8.50 )
MCK' s 10-Year Dividend growth (3y) Range
Min: -21.7   Max: 44.2
Current: 8.5

-21.7
44.2
Yield on cost (5-Year) 0.81
MCK's Yield on cost (5-Year) is ranked lower than
88% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.04 vs. MCK: 0.81 )
MCK' s 10-Year Yield on cost (5-Year) Range
Min: 0.71   Max: 2.87
Current: 0.81

0.71
2.87
Share Buyback Rate 4.00
MCK's Share Buyback Rate is ranked higher than
92% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.20 vs. MCK: 4.00 )
MCK' s 10-Year Share Buyback Rate Range
Min: 4.3   Max: -43.4
Current: 4

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.40
MCK's Price/DCF (Projected) is ranked higher than
90% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.07 vs. MCK: 1.40 )
MCK' s 10-Year Price/DCF (Projected) Range
Min: 0.55   Max: 17.04
Current: 1.4

0.55
17.04
Price/Median PS Value 1.82
MCK's Price/Median PS Value is ranked higher than
62% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.31 vs. MCK: 1.82 )
MCK' s 10-Year Price/Median PS Value Range
Min: 0.01   Max: 4.46
Current: 1.82

0.01
4.46
Price/Peter Lynch Fair Value 2.23
MCK's Price/Peter Lynch Fair Value is ranked higher than
86% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.00 vs. MCK: 2.23 )
MCK' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.34   Max: 72.67
Current: 2.23

0.34
72.67
Earnings Yield (Greenblatt) 5.10
MCK's Earnings Yield (Greenblatt) is ranked higher than
67% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. MCK: 5.10 )
MCK' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.3   Max: 16.5
Current: 5.1

4.3
16.5
Forward Rate of Return (Yacktman) 17.67
MCK's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.49 vs. MCK: 17.67 )
MCK' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -1141   Max: 102.1
Current: 17.67

-1141
102.1

Analyst Estimate

Mar15 Mar16 Mar17
Revenue(Mil) 178,073 187,986 198,594
EPS($) 10.56 12.60 15.12
EPS without NRI($) 10.56 12.60 15.12

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, CAH, SHTDF, HSIC, PDCO » details
Traded in other countries:MCK.Germany, MCK.Mexico,
McKesson Corporation is a Delaware Corporation. The Company delivers pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment and health and beauty care products throughout North America and internationally. This segment provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. This segment also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers through a network of distribution centers within the U.S. In addition, this segment sells financial, operational and clinical solutions for pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services. The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes its InterQual clinical criteria solution, claims payment solutions and network performance tools. This segment also delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. This segment's customers include hospitals, physicians, homecare providers, retail pharmacies and payers primarily from North America. McKesson Distribution Solutions consists of the following businesses: North America pharmaceutical distribution and services, International pharmaceutical distribution and services and Medical Surgical distribution and services. The Company competes with other software services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, payers, care management organizations, hardware vendors and internet-based companies with technology applicable to the healthcare industry.
» More Articles for MCK

Headlines

Articles On GuruFocus.com
Rite Aid Corporation is a Buy Feb 19 2015 
Manson Creek Terminates Option on Uptown Gold Property, NWT Dec 22 2014 
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
A Few Reasons Why McKesson Could Be a Good Investment Dec 11 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
CPSI: A Predictable And Undervalued Small Cap Dec 05 2014 
Rite Aid Corporation Looks Promising Dec 05 2014 
McKesson's Growth Is Set to Continue in the Long Run Nov 25 2014 
Weekly Insider Sells Highlight: FB, DVA, DATA, MCK, TXN Nov 18 2014 
Weekly Highlight of CEO Sells Oct 13 2014 


More From Other Websites
McKesson Appoints Bansi Nagji to Executive Vice President of Corporate Strategy and Business... Feb 26 2015
McKesson Honored as a ‘Best Place to Work’ for Second Year in a Row by Human Rights Campaign... Feb 26 2015
Eight Health Plans Choose McKesson’s Network Management Solutions Feb 25 2015
These 5 Big Caps Hit New Closing Highs Feb 25 2015
Express Scripts (ESRX) Beats on Q4 Earnings & Revenues - Analyst Blog Feb 24 2015
Monday's Market Recap Feb 23 2015
LabCorp Beats Q4 Earnings, Positive on Covance Addition - Analyst Blog Feb 20 2015
McKesson Corp. revealed as the Clear Lake mystery company Feb 19 2015
McKesson Corp. revealed as the Clear Lake mystery company Feb 19 2015
13 Health Plans Invest in McKesson’s Latest ClaimsXten Solution for Accurate and Efficient... Feb 19 2015
DENTSPLY Lags Q4 Earnings, Revenues; FY15 Outlook Grim - Analyst Blog Feb 18 2015
Over 600 Payers, Providers Chose McKesson InterQual® Criteria for Clinical Decision Support Feb 17 2015
McKesson Appoints Bansi Nagji to Executive Vice President of Corporate Strategy and Business... Feb 17 2015
McKesson division snags 50,000 square feet in East Bay tower Feb 13 2015
McKesson Corporation to Present at the Cowen and Company 35th Annual Health Care Conference Feb 13 2015
McKesson Medical-Surgical Introduces New Advanced Skin and Wound Care Product Portfolio Feb 13 2015
McKesson Reports Fiscal 2015 Third-Quarter Results Feb 13 2015
iKnowMed Named Top-Performing Electronic Health Record (EHR) for Oncology and Hematology Practices... Feb 13 2015
MCKESSON CORP Financials Feb 12 2015
Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog Feb 11 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK